Alzheimer's drug Leqembi off to slow start after FDA approval

The Food and Drug Administration gave Leqembi full approval last summer for patients with early stages of the disease. But sales have lagged.

Related Keywords

Arizona ,United States ,Alabama ,Mayo Clinic In Rochester ,Minnesota ,Florida ,Phoenix ,Texas ,Americans ,Eric Widera ,David Evans ,Sarah Kremen ,Alexander Scott ,Alireza Atri ,Ron Petersen ,Eli Lilly ,Ambar Kulshreshtha ,Scott Berkheiser ,Los Angeles ,Banner Health ,Drug Administration ,University Of California San Francisco ,Mayo Clinic ,California San ,